-
EP1100781
European procedure
Extract from the Register of European Patents
EP About this file: EP1100781
| EP1100781 - HIGH AFFINITY LIGANDS FOR NOCICEPTIN RECEPTOR ORL-1 [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.07.2005 Database last updated on 12.07.2024 | Most recent event Tooltip | 29.07.2005 | No opposition filed within time limit | published on 14.09.2005 [2005/37] | Applicant(s) | For all designated states Schering Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 / US | [N/P] |
| Former [2001/21] | For all designated states SCHERING CORPORATION 2000 Galloping Hill Road Kenilworth, New Jersey 07033-0530 / US | Inventor(s) | 01 /
TULSHIAN, Deen 4 Saddle Ridge Drive Lebanon, NJ 08833 / US | 02 /
HO, Ginny, D. 42 Chestnut Hill Drive Murray Hill, NJ 07974 / US | 03 /
SILVERMAN, Lisa, S. 214 Hana Road Edison, NJ 08817 / US | 04 /
MATASI, Julius, J. 16 Putnam Road Monmouth Junction New Jersey 08852 / US | 05 /
McLEOD, Robbie, L. 13 Creek Trail Branchburg, NJ 08876 / US | 06 /
HEY, John A. 23 Willow Avenue Randolph, New Jersey 07869 / US | 07 /
CHAPMAN, Richard, W. 30 Ditmars Circle Somerville, NJ 08876 / US | 08 /
BERCOVICI, Ana 1 Howell Drive West Orange, NJ 07052 / US | 09 /
CUSS, Francis, M. 111 Rippling Brook Way Bernardsville, NJ 07924 / US | [2001/22] |
| Former [2001/21] | 01 /
TULSHIAN, Deen 4 Saddle Ridge Drive Lebanon, NJ 08833 / US | ||
| 02 /
HO, Ginny, D. 42 Chestnut Hill Drive Murray Hill, NJ 07974 / US | |||
| 03 /
SILVERMAN, Lisa, S. 214 Hana Road Edison, NJ 08817 / US | |||
| 04 /
MATASI, Julius, J. 129 Spruce Mill Lane Scotch Plains, NJ 07076 / US | |||
| 05 /
McLEOD, Robbie, L. 13 Creek Trail Branchburg, NJ 08876 / US | |||
| 06 /
HEY, John A. 23 Willow Avenue Randolph, New Jersey 07869 / US | |||
| 07 /
CHAPMAN, Richard, W. 30 Ditmars Circle Somerville, NJ 08876 / US | |||
| 08 /
BERCOVICI, Ana 1 Howell Drive West Orange, NJ 07052 / US | |||
| 09 /
CUSS, Francis, M. 111 Rippling Brook Way Bernardsville, NJ 07924 / US | Representative(s) | Ritter, Stephen David, et al Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB | [N/P] |
| Former [2001/21] | Ritter, Stephen David, et al Mathys & Squire 100 Grays Inn Road London WC1X 8AL / GB | Application number, filing date | 99937174.3 | 26.07.1999 | [2001/21] | WO1999US14165 | Priority number, date | US19980122878 | 27.07.1998 Original published format: US 122878 | [2001/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0006545 | Date: | 10.02.2000 | Language: | EN | [2000/06] | Type: | A1 Application with search report | No.: | EP1100781 | Date: | 23.05.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.02.2000 takes the place of the publication of the European patent application. | [2001/21] | Type: | B1 Patent specification | No.: | EP1100781 | Date: | 22.09.2004 | Language: | EN | [2004/39] | Search report(s) | International search report - published on: | EP | 10.02.2000 | Classification | IPC: | C07D211/52, C07D211/58, C07D471/10, C07D401/04, A61K31/445, // (C07D471/10, 235:00), C07D221:00 | [2001/21] | CPC: |
C07D221/20 (EP);
C07D401/14 (KR);
A61K31/445 (EP);
A61K45/06 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P11/10 (EP);
A61P11/14 (EP);
A61P23/00 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/26 (EP);
A61P25/32 (EP);
A61P25/34 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
C07D211/14 (EP);
C07D211/22 (EP);
C07D211/26 (EP);
C07D211/28 (EP);
C07D211/32 (EP);
C07D211/34 (EP);
C07D211/52 (EP);
C07D211/64 (EP);
C07D235/26 (EP);
C07D401/04 (EP);
C07D401/06 (EP);
C07D401/12 (EP);
C07D405/04 (EP);
C07D405/12 (EP);
C07D409/04 (EP);
C07D409/06 (EP);
C07D409/12 (EP);
C07D417/04 (EP);
C07D451/14 (EP);
| C-Set: |
A61K31/445, A61K2300/00 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/21] | Extension states | RO | 10.01.2001 | SI | 10.01.2001 | Title | German: | LIGANDEN MIT HOHER AFFINITÄT FÜR DEN NOCICEPTIN-REZEPTOR ORL-1 | [2001/21] | English: | HIGH AFFINITY LIGANDS FOR NOCICEPTIN RECEPTOR ORL-1 | [2001/21] | French: | LIGANDS D'AFFINITE ELEVEE POUR RECEPTEUR DE LA NOCICEPTINE ORL-1 | [2001/21] | Entry into regional phase | 10.01.2001 | National basic fee paid | 10.01.2001 | Designation fee(s) paid | 10.01.2001 | Examination fee paid | Examination procedure | 12.01.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 10.01.2001 | Examination requested [2001/21] | 15.01.2002 | Despatch of a communication from the examining division (Time limit: M08) | 13.08.2002 | Reply to a communication from the examining division | 20.10.2003 | Communication of intention to grant the patent | 28.04.2004 | Fee for grant paid | 28.04.2004 | Fee for publishing/printing paid | Divisional application(s) | EP02018161.6 / EP1258244 | Opposition(s) | 23.06.2005 | No opposition filed within time limit [2005/37] | Fees paid | Renewal fee | 05.07.2001 | Renewal fee patent year 03 | 04.07.2002 | Renewal fee patent year 04 | 04.07.2003 | Renewal fee patent year 05 | 09.07.2004 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US3311624 (GERHARD OHNACKER, et al) [X] 1,10,14 * column 23, line 45 - line 71; example -; claims 1,2 *; | [AD]US3318900 (JAN JANSSEN PAUL ADRIAAN) [AD] 1,10 * column 1, line 14 - line 66 *; | [X]EP0121972 (JANSSEN PHARMACEUTICA NV [BE]) [X] 1 * page 38, line 18 - line 19 *; | [A]US4521537 (KOSLEY JR RAYMOND W [US], et al) [A] 1 * tables I-III *; | [X]EP0709375 (ZENECA LTD [GB]) [X] 1 * page 28, compound IX *; | [X]DE19519245 (BOEHRINGER INGELHEIM KG [DE]) [X] 1,10,14 * page 4, line 63 - page 5, line 2; examples 11,48; claims 1,10 *; | [A]EP0743312 (ADIR [FR]) [A] 1 * examples 6,22 *; | [X]US5583000 (ORTIZ DE MONTELLANO PAUL R [US], et al) [X] 1 * table 1, compound code no. UCSF2, UCSF24, UCSF32, UCSF33, UCSF46, UCSF54, UCSF55, UCSF56, UCSF57, UCSF61, UCSF73 *; | [AD]WO9728797 (MERCK & CO INC [US], et al); | [ADP]EP0856514 (HOFFMANN LA ROCHE [CH]) [ADP] 1,7,9-11,14 * claims 1,12,13 *; | [ADP]WO9854168 (BANYU PHARMA CO LTD [JP], et al) [ADP] 1,10,11,14 * abstract *; | [X] - G. HENDERSON ET AL., TRENDS IN PHARMACOLOGICAL SCIENCES, (199708), vol. 18, pages 293 - 300, XP004085920 [X] 1 * page 296, compound "Lofentanyl"; page 297, table, "Lofentanyl" * DOI: http://dx.doi.org/10.1016/S0165-6147(97)90645-3 |